Logo image of GMED

GLOBUS MEDICAL INC - A (GMED) Stock Price, Quote, News and Overview

NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD

70.5  -1.41 (-1.96%)

After market: 70.5 0 (0%)

GMED Quote, Performance and Key Statistics

GLOBUS MEDICAL INC - A

NYSE:GMED (5/5/2025, 8:14:51 PM)

After market: 70.5 0 (0%)

70.5

-1.41 (-1.96%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High94.93
52 Week Low62.13
Market Cap9.54B
Shares135.35M
Float112.14M
Yearly DividendN/A
Dividend YieldN/A
PE22.45
Fwd PE20.09
Earnings (Next)05-08 2025-05-08/amc
IPO03-08 2012-03-08


GMED short term performance overview.The bars show the price performance of GMED in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

GMED long term performance overview.The bars show the price performance of GMED in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of GMED is 70.5 USD. In the past month the price increased by 2.43%. In the past year, price increased by 8.93%.

GLOBUS MEDICAL INC - A / GMED Daily stock chart

GMED Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.74 229.97B
ISRG INTUITIVE SURGICAL INC 69.61 190.61B
BSX BOSTON SCIENTIFIC CORP 38.61 154.18B
SYK STRYKER CORP 30.44 145.56B
MDT MEDTRONIC PLC 15.63 107.03B
BDX BECTON DICKINSON AND CO 11.85 47.95B
EW EDWARDS LIFESCIENCES CORP 28.89 44.16B
IDXX IDEXX LABORATORIES INC 41.67 38.50B
RMD RESMED INC 26.5 35.29B
GEHC GE HEALTHCARE TECHNOLOGY 15.08 31.76B
DXCM DEXCOM INC 48.65 31.47B
PHG KONINKLIJKE PHILIPS NVR- NY 16.33 24.10B

About GMED

Company Profile

GMED logo image Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,300 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

Company Info

GLOBUS MEDICAL INC - A

2560 General Armistead Ave

Audubon PENNSYLVANIA 19403 US

CEO: David M. Demski

Employees: 5300

GMED Company Website

GMED Investor Relations

Phone: 16109301800

GLOBUS MEDICAL INC - A / GMED FAQ

What is the stock price of GLOBUS MEDICAL INC - A today?

The current stock price of GMED is 70.5 USD. The price decreased by -1.96% in the last trading session.


What is the ticker symbol for GLOBUS MEDICAL INC - A stock?

The exchange symbol of GLOBUS MEDICAL INC - A is GMED and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is GMED stock listed?

GMED stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for GLOBUS MEDICAL INC - A stock?

22 analysts have analysed GMED and the average price target is 99.41 USD. This implies a price increase of 41.01% is expected in the next year compared to the current price of 70.5. Check the GLOBUS MEDICAL INC - A stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GLOBUS MEDICAL INC - A worth?

GLOBUS MEDICAL INC - A (GMED) has a market capitalization of 9.54B USD. This makes GMED a Mid Cap stock.


How many employees does GLOBUS MEDICAL INC - A have?

GLOBUS MEDICAL INC - A (GMED) currently has 5300 employees.


What are the support and resistance levels for GLOBUS MEDICAL INC - A (GMED) stock?

GLOBUS MEDICAL INC - A (GMED) has a support level at 69.75 and a resistance level at 70.68. Check the full technical report for a detailed analysis of GMED support and resistance levels.


Is GLOBUS MEDICAL INC - A (GMED) expected to grow?

The Revenue of GLOBUS MEDICAL INC - A (GMED) is expected to grow by 7.64% in the next year. Check the estimates tab for more information on the GMED EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy GLOBUS MEDICAL INC - A (GMED) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GLOBUS MEDICAL INC - A (GMED) stock pay dividends?

GMED does not pay a dividend.


When does GLOBUS MEDICAL INC - A (GMED) report earnings?

GLOBUS MEDICAL INC - A (GMED) will report earnings on 2025-05-08, after the market close.


What is the Price/Earnings (PE) ratio of GLOBUS MEDICAL INC - A (GMED)?

The PE ratio for GLOBUS MEDICAL INC - A (GMED) is 22.45. This is based on the reported non-GAAP earnings per share of 3.14 and the current share price of 70.5 USD. Check the full fundamental report for a full analysis of the valuation metrics for GMED.


What is the Short Interest ratio of GLOBUS MEDICAL INC - A (GMED) stock?

The outstanding short interest for GLOBUS MEDICAL INC - A (GMED) is 3.71% of its float. Check the ownership tab for more information on the GMED short interest.


GMED Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to GMED. When comparing the yearly performance of all stocks, GMED turns out to be only a medium performer in the overall market: it outperformed 40.7% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

GMED Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GMED. Both the profitability and the financial health of GMED get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GMED Financial Highlights

Over the last trailing twelve months GMED reported a non-GAAP Earnings per Share(EPS) of 3.14. The EPS increased by 34.76% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.09%
ROA 1.96%
ROE 2.47%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%40%
Sales Q2Q%6.61%
EPS 1Y (TTM)34.76%
Revenue 1Y (TTM)60.63%

GMED Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to GMED. The Buy consensus is the average rating of analysts ratings from 22 analysts.

For the next year, analysts expect an EPS growth of 11.73% and a revenue growth 7.64% for GMED


Ownership
Inst Owners98.44%
Ins Owners0.76%
Short Float %3.71%
Short Ratio3.34
Analysts
Analysts80
Price Target99.41 (41.01%)
EPS Next Y11.73%
Revenue Next Year7.64%